Abstract:The chromosome-centric human proteome project (C-HPP) has made great progress of finding protein evidence (PE) for missing proteins (PE2-4 proteins defined by the neXtProt), which now becomes an increasingly challenging field. As a majority of samples tested in this field were from adult tissues/cells, the developmental stage specific or relevant proteins could be missed due to biological source availability. We posit that epigenetic interventions may help to partially bypass such a limitation by stimulating the expression of the "silenced" genes in adult cells, leading to the increased chance of finding missing proteins. In this study, we established in vitro human cell models to modify the histone acetylation, demethylation, and methylation with near physiological conditions. With mRNA-seq analysis, we found that histone modifications resulted in overall increases of expressed genes in an even distribution manner across different chromosomes. We identified 64 PE2-4 and six PE5 proteins by MaxQuant (FDR < 1% at both protein and peptide levels) and 44 PE2-4 and 7 PE5 proteins by Mascot (FDR < 1% at peptide level) searches, respectively. However, only 24 PE2-4 and five PE5 proteins in Mascot, and 12 PE2-4 and one PE5 proteins in MaxQuant searches could, respectively, pass our stringently manual spectrum inspections. Collectively, 27 PE2-4 and five PE5 proteins were identified from the epigenetically modified cells; among them, 19 PE2-4 and three PE5 proteins passed FDR < 1% at both peptide and protein levels. Gene ontology analyses revealed that the PE2-4 proteins were significantly involved in development and spermatogenesis, although their chemical-physical features had no statistical difference from the background. In addition, we presented an example of suspicious PE5 peptide spectrum matched with unusual AA substitutions related to post-translational modification. In conclusion, the epigenetically manipulated cell models should be a useful tool for finding missing proteins in C-HPP. The mass spectrometry data have been deposited to the iProx database (accession number: IPX00020200).

Multiproteases Combined with High-pH Reverse-Phase Separation Strategy Verified Fourteen Missing Proteins in Human Testis Tissue

Multi-Protease Strategy Identifies Three PE2 Missing Proteins in Human Testis Tissue

Open-pFind Verified Four Missing Proteins from Multi-Tissues

Digging for Missing Proteins Using Low-Molecular-Weight Protein Enrichment and a “mirror Protease” Strategy

Tissue-Based Proteogenomics Reveals that Human Testis Endows Plentiful Missing Proteins

Deep Coverage Proteomics Identifies More Low-Abundance Missing Proteins in Human Testis Tissue with Q-Exactive HF Mass Spectrometer

Open-pFind Enhances the Identification of Missing Proteins from Human Testis Tissue

Exploration of Missing Proteins by a Combination Approach to Enrich the Low-Abundance Hydrophobic Proteins from Four Cancer Cell Lines

Special Enrichment Strategies Greatly Increase the Efficiency of Missing Proteins Identification from Regular Proteome Samples

A fully automated system with online sample loading, isotope dimethyl labeling and multidimensional separation for high-throughput quantitative proteome analysis.

Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer.

Digging More Missing Proteins Using an Enrichment Approach with ProteoMiner

Alternative Strategy to Explore Missing Proteins with Low Molecular Weight

Finding Missing Proteins from the Epigenetically Manipulated Human Cell with Stringent Quality Criteria.

Screening of Missing Proteins in the Human Liver Proteome by Improved MRM-approach-based Targeted Proteomics.

Improvement of Peptide Separation for Exploring the Missing Proteins Localized on Membranes

Scanning of novel cancer/testis proteins by human testis proteomic analysis.

Systematic Analyses of the Transcriptome, Translatome, and Proteome Provide a Global View and Potential Strategy for the C-HPP.

Large-scale Phosphoproteome Analysis of Human Liver Tissue by Enrichment and Fractionation of Phosphopeptides with Strong Anion Exchange Chromatography.

Comprehensive Peptidome Analysis Of Mouse Livers By Size Exclusion Chromatography Prefractionation And Nanolc-Ms/Ms Identification

Improving Deep Proteome and PTMome Coverage Using Tandem HILIC-HPRP Peptide Fractionation Strategy